JPS5123537Y2 - - Google Patents

Info

Publication number
JPS5123537Y2
JPS5123537Y2 JP836672U JP836672U JPS5123537Y2 JP S5123537 Y2 JPS5123537 Y2 JP S5123537Y2 JP 836672 U JP836672 U JP 836672U JP 836672 U JP836672 U JP 836672U JP S5123537 Y2 JPS5123537 Y2 JP S5123537Y2
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP836672U
Other languages
Japanese (ja)
Other versions
JPS4881032U (zh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to JP836672U priority Critical patent/JPS5123537Y2/ja
Publication of JPS4881032U publication Critical patent/JPS4881032U/ja
Application granted granted Critical
Publication of JPS5123537Y2 publication Critical patent/JPS5123537Y2/ja
Expired legal-status Critical Current

Links

JP836672U 1972-01-17 1972-01-17 Expired JPS5123537Y2 (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP836672U JPS5123537Y2 (zh) 1972-01-17 1972-01-17

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP836672U JPS5123537Y2 (zh) 1972-01-17 1972-01-17

Publications (2)

Publication Number Publication Date
JPS4881032U JPS4881032U (zh) 1973-10-03
JPS5123537Y2 true JPS5123537Y2 (zh) 1976-06-17

Family

ID=27851630

Family Applications (1)

Application Number Title Priority Date Filing Date
JP836672U Expired JPS5123537Y2 (zh) 1972-01-17 1972-01-17

Country Status (1)

Country Link
JP (1) JPS5123537Y2 (zh)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9308281B2 (en) 2011-06-08 2016-04-12 Shire Human Genetic Therapies, Inc. MRNA therapy for Fabry disease
US9522176B2 (en) 2013-10-22 2016-12-20 Shire Human Genetic Therapies, Inc. MRNA therapy for phenylketonuria

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9308281B2 (en) 2011-06-08 2016-04-12 Shire Human Genetic Therapies, Inc. MRNA therapy for Fabry disease
US9597413B2 (en) 2011-06-08 2017-03-21 Shire Human Genetic Therapies, Inc. Pulmonary delivery of mRNA
US9522176B2 (en) 2013-10-22 2016-12-20 Shire Human Genetic Therapies, Inc. MRNA therapy for phenylketonuria

Also Published As

Publication number Publication date
JPS4881032U (zh) 1973-10-03

Similar Documents

Publication Publication Date Title
JPS5417432B2 (zh)
FR2197036B1 (zh)
FR2211250B1 (zh)
FR2210677B1 (zh)
JPS535036B2 (zh)
JPS49872U (zh)
JPS4881032U (zh)
JPS5339620B2 (zh)
JPS4975367U (zh)
JPS5221545Y2 (zh)
JPS5223120Y2 (zh)
JPS524835B2 (zh)
JPS4971289A (zh)
JPS5460676U (zh)
FR2196340A1 (zh)
BG18294A1 (zh)
BG22089A3 (zh)
BG20538A3 (zh)
CH573062A5 (zh)
BG26813A3 (zh)
CH562737A5 (zh)
CH545667A (zh)
CH559156A5 (zh)
CH562628A5 (zh)
BG18969A1 (zh)